esophageal cancer Lucid Diagnostics Obtains CE Mark for Esophageal Cancer Molecular Test Lucid said that key opinion leaders for esophageal disease in Europe are participating in pivotal clinical trials for the test and its collection device. Stella Diagnostics, Mayo Clinic Collaborating on Barrett's Esophagus Protein Markers The partners will use mass spec to look at markers in Barrett's patients who either progressed to more severe disease states or remained stable over a 10-year period. Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year. Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test The firm presented initial study results from the test, which identifies six cancers, showing overall sensitivity at 86 percent and specificity of 95 percent. Early Copy Number Changes Predict Progression of Barrett's Esophagus to Esophageal Cancer The findings suggested that genomic surveillance of Barrett's esophagus could identify patients who will progress years in advance and enable earlier treatment. Aug 6, 2020 PavMed Raises $7M in Private Funding Round Jul 1, 2020 AnchorDx Demonstrates Liquid Biopsy DNA Methylation Test for Early Cancer Detection Premium May 11, 2020 Genetic Ancestry Linked to Differences in Molecular Features of Cancers Apr 8, 2020 Esophageal Cancer Case Study Suggests Utility as Clinicians Explore Expanded Uses for Liquid Biopsy Premium Feb 25, 2020 Capsulomics, Johns Hopkins Partner on Esophageal Cancer, Barrett's Esophagus Research Feb 20, 2020 Lucid Diagnostics, Fred Hutchinson Cancer Research Center Ink Esophageal Cancer Biomarker Deal Feb 13, 2020 Lucid Diagnostics EsoGuard DNA Test Gets FDA Breakthrough Device Status Jan 6, 2020 Interpace Biosciences, University of North Carolina Launch Barrett's Esophagus Study Aug 13, 2019 Interpace Diagnostics Q2 Revenues Climb 14 Percent May 8, 2019 Almac Assay's Ability to Stratify Esophageal Cancer Patients Demonstrated by UK Researchers Premium Feb 11, 2019 Johns Hopkins Team to Commercialize Barrett's Esophagus Epigenetic Biomarker Panel Premium Feb 4, 2019 Esophageal Cancer Analysis Reveals Driver, Prognostic Alterations Jan 2, 2019 Cancer Driver Gene Mutations Rise with Age in Otherwise Normal Esophageal Tissue Nov 13, 2018 Interpace Diagnostics Q3 Revenues Up 38 Percent Oct 18, 2018 Healthy Esophageal Tissue Often Marked by Cancer-Related Mutations Aug 9, 2018 Interpace Q2 Revenues Spike 41 Percent May 29, 2018 PavMed Spinoff Lucid Diagnostics Aims to Market Molecular Barrett's Esophagus Test in 2019 Premium May 14, 2018 Lucid Diagnostics Licenses Barrett's Esophagus Biomarker Tech from CWRU Jan 29, 2018 Esophageal Cancer GWAS Leads to Low-Frequency Risk Variants Dec 7, 2017 UCSF Team Studying Genomics of Rare Cancers With Geographic Hotspots Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.